TOBIN JAMES R — SEC Form 4 filings
SEC reporting owner CIK 1190128. 15 Form 4 filings on record with FilingPulse; latest filed 2026-09-16.
Transaction summary — filings shown
Covers all 15 filings on record, filed 2024-01-30 to 2026-09-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 14 legs across 5 filings — 90,445 shares, $9,647,312 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 16.
- Largest priced transaction: sale of 30,000 shares @ $74.58 ($2,237,502) in GLOBUS MEDICAL INC, filed 2026-09-16.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TransMedics Group, Inc. (TMDX) | Director | 9 | — | 13 legs · 60,445 sh · $7,409,810 | 7 |
| GLOBUS MEDICAL INC (GMED) | Director | 4 | — | 1 leg · 30,000 sh · $2,237,502 | 7 |
| Lyra Therapeutics, Inc. (LYRA) | Director | 2 | — | — | 2 |
Form 4 filings — TOBIN JAMES R
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-16 | 4 | GLOBUS MEDICAL INC (GMED) | Option exercise (M): 15,000 @ $53.75 · Option exercise (M): 15,000 @ $63.68 · Sale (S): 30,000 @ $74.58 · Option exercise (M): 15,000 (derivative) @ $0 · Option exercise (M): 15,000 (derivative) @ $0 | EDGAR |
| 2026-08-17 | 4 | TransMedics Group, Inc. (TMDX) | Gift (G): 18,000 @ $0 | EDGAR |
| 2026-05-22 | 4 | TransMedics Group, Inc. (TMDX) | Grant/award (A): 2,922 @ $0 | EDGAR |
| 2026-01-23 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2025-05-23 | 4 | TransMedics Group, Inc. (TMDX) | Grant/award (A): 2,134 @ $0 | EDGAR |
| 2025-05-16 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 32,000 (derivative) @ $0 | EDGAR |
| 2025-03-28 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2024-09-17 | 4 | TransMedics Group, Inc. (TMDX) | Gift (G): 18,000 @ $0 · Gift (G): 18,000 @ $0 | EDGAR |
| 2024-08-09 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 12,664 @ $158.96 · Sale (S): 7,336 @ $159.96 | EDGAR |
| 2024-06-14 | 4 | Lyra Therapeutics, Inc. (LYRA) | Grant/award (A): 30,000 (derivative) @ $0 | EDGAR |
| 2024-05-28 | 4 | TransMedics Group, Inc. (TMDX) | Grant/award (A): 732 @ $0 · Grant/award (A): 1,154 (derivative) @ $0 | EDGAR |
| 2024-05-07 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 5,130 @ $124.76 · Sale (S): 6,895 @ $125.26 | EDGAR |
| 2024-05-03 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 11,236 @ $105.70 · Sale (S): 1,704 @ $106.89 · Sale (S): 100 @ $108.47 · Sale (S): 2,000 @ $110 | EDGAR |
| 2024-03-05 | 4 | TransMedics Group, Inc. (TMDX) | Sale (S): 200 @ $81.41 · Sale (S): 4,234 @ $82.84 · Sale (S): 5,746 @ $83.63 · Sale (S): 2,900 @ $84.74 · Sale (S): 300 @ $85.48 | EDGAR |
| 2024-01-30 | 4 | GLOBUS MEDICAL INC (GMED) | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1190128 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →